Company profile

Betta Pharmaceuticals Co.

300558 · SZSE (ChiNext)

Public Market Listing

300558SZSE (ChiNext)

SZSE (ChiNext) primary exchange listing

Live quotes, historical charts, and market capitalization for Betta Pharmaceuticals Co. are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(7 total)
7Total Assets
0Approved
3Phase 3 / Filed
4Phase 1–2 / Early
2Diseases
Quick filter:
Showing 7 of 7 assets
Target & Modality
Befotertinib
Phase 3
EGFRSmall molecule
Non-Small Cell Lung Cancer
BPI-16350
Phase 3
CDK4 and CDK6Small molecule
HR+/HER2- Breast Cancer
HR+/HER2- Metastatic Breast Cancer
Icotinib
Phase 3
EGFRSmall molecule
Non-Small Cell Lung Cancer
BPI-361175
Phase 2
EGFRSmall molecule
Non-Small Cell Lung Cancer
BPI-572270
Phase 2
RAS (pan-RAS, RAS-mutant tumors)Small molecule
Non-Small Cell Lung Cancer
BPI-371153
Phase 1
PD-L1Small molecule
Non-Small Cell Lung Cancer
CFT8919
Phase 1
EGFR L858R (including T790M/C797S resistant mutants)Small molecule
Non-Small Cell Lung Cancer

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.